• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依赖 RNase H 的 Gapmer 反义寡核苷酸对日本脑炎病毒的抗病毒功效。

Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus.

机构信息

Laboratory of Preventive Veterinary Medicine and Animal Health, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Fujisawa, Kanagawa 252-0880, Japan.

Nihon University Veterinary Research Center, Fujisawa, Kanagawa 252-0880, Japan.

出版信息

Int J Mol Sci. 2023 Oct 2;24(19):14846. doi: 10.3390/ijms241914846.

DOI:10.3390/ijms241914846
PMID:37834294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10573891/
Abstract

RNase H-dependent gapmer antisense oligonucleotides (ASOs) are a promising therapeutic approach via sequence-specific binding to and degrading target RNAs. However, the efficacy and mechanism of antiviral gapmer ASOs have remained unclear. Here, we investigated the inhibitory effects of gapmer ASOs containing locked nucleic acids (LNA gapmers) on proliferating a mosquito-borne flavivirus, Japanese encephalitis virus (JEV), with high mortality. We designed several LNA gapmers targeting the 3' untranslated region of JEV genomic RNAs. In vitro screening by plaque assay using Vero cells revealed that LNA gapmers targeting a stem-loop region effectively inhibit JEV proliferation. Cell-based and RNA cleavage assays using mismatched LNA gapmers exhibited an underlying mechanism where the inhibition of viral production results from JEV RNA degradation by LNA gapmers in a sequence- and modification-dependent manner. Encouragingly, LNA gapmers potently inhibited the proliferation of five JEV strains of predominant genotypes I and III in human neuroblastoma cells without apparent cytotoxicity. Database searching showed a low possibility of off-target binding of our LNA gapmers to human RNAs. The target viral RNA sequence conservation observed here highlighted their broad-spectrum antiviral potential against different JEV genotypes/strains. This work will facilitate the development of an antiviral LNA gapmer therapy for JEV and other flavivirus infections.

摘要

依赖 RNase H 的 gapmer 反义寡核苷酸(ASO)是一种有前途的治疗方法,通过与靶 RNA 特异性结合并降解靶 RNA。然而,抗病毒 gapmer ASO 的疗效和机制仍不清楚。在这里,我们研究了含有锁核酸(LNA gapmer)的 gapmer ASO 对高致死性增殖的蚊传黄病毒、日本脑炎病毒(JEV)的抑制作用。我们设计了几种针对 JEV 基因组 RNA 的 3'非翻译区的 LNA gapmer。使用 Vero 细胞通过蚀斑测定进行的体外筛选表明,针对茎环结构的 LNA gapmer 可有效抑制 JEV 的增殖。使用错配的 LNA gapmer 的基于细胞和 RNA 切割的测定表明,抑制病毒产生的机制是 LNA gapmer 通过序列和修饰依赖性方式降解 JEV RNA。令人鼓舞的是,LNA gapmer 在没有明显细胞毒性的情况下,强烈抑制了人神经母细胞瘤细胞中五种主要基因型 I 和 III 的 JEV 株的增殖。数据库搜索显示,我们的 LNA gapmer 与人 RNA 发生非靶标结合的可能性较低。这里观察到的靶病毒 RNA 序列保守性突出了它们对不同 JEV 基因型/株的广谱抗病毒潜力。这项工作将促进用于 JEV 和其他黄病毒感染的抗病毒 LNA gapmer 治疗的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8542dbd4dc4f/ijms-24-14846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/132f6cc1c9dc/ijms-24-14846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8619c8bdc240/ijms-24-14846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/195d13576770/ijms-24-14846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8964f8d1e77e/ijms-24-14846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/50d758205275/ijms-24-14846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/67f3e5d4ae38/ijms-24-14846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8542dbd4dc4f/ijms-24-14846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/132f6cc1c9dc/ijms-24-14846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8619c8bdc240/ijms-24-14846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/195d13576770/ijms-24-14846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8964f8d1e77e/ijms-24-14846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/50d758205275/ijms-24-14846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/67f3e5d4ae38/ijms-24-14846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5d/10573891/8542dbd4dc4f/ijms-24-14846-g007.jpg

相似文献

1
Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus.依赖 RNase H 的 Gapmer 反义寡核苷酸对日本脑炎病毒的抗病毒功效。
Int J Mol Sci. 2023 Oct 2;24(19):14846. doi: 10.3390/ijms241914846.
2
An Investigation into the Potential of Targeting mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy.靶向信使 RNA 的Locked Nucleic Acid (LNA) Gapmers 作为一种抗菌策略的研究
Molecules. 2021 Jun 4;26(11):3414. doi: 10.3390/molecules26113414.
3
Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.锁核酸修饰的gapmer反义寡核苷酸引起的核糖核酸酶H1依赖性肝毒性。
Sci Rep. 2016 Jul 27;6:30377. doi: 10.1038/srep30377.
4
Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site.新型强效抗病毒锁核酸反义寡核苷酸针对丙型肝炎病毒内部核糖体进入位点的选择、优化及药代动力学特性。
Antimicrob Agents Chemother. 2011 Jul;55(7):3105-14. doi: 10.1128/AAC.00222-11. Epub 2011 Apr 18.
5
RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.基于含8-氧代脱氧鸟苷修饰的反义锁核酸寡核苷酸的RNA干扰引导靶向丙型肝炎病毒复制
PLoS One. 2015 Jun 3;10(6):e0128686. doi: 10.1371/journal.pone.0128686. eCollection 2015.
6
Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.填补锁核酸(LNA)反义寡核苷酸缺口嵌合体的空白:解锁核酸(UNA)和4'-C-羟甲基-DNA修饰对核糖核酸酶H募集及LNA缺口嵌合体疗效的影响
Mol Biosyst. 2009 Aug;5(8):838-43. doi: 10.1039/b903922h. Epub 2009 May 19.
7
Fine-tuning of ENA gapmers as antisense oligonucleotides for sequence-specific inhibition.作为用于序列特异性抑制的反义寡核苷酸的 ENA 间隙嵌合体的微调。
Oligonucleotides. 2007 Fall;17(3):291-301. doi: 10.1089/oli.2007.0078.
8
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.高亲和力缺口mer反义寡核苷酸的肝毒性是由RNase H1依赖性的超长前体mRNA转录本的混杂减少介导的。
Nucleic Acids Res. 2016 Mar 18;44(5):2093-109. doi: 10.1093/nar/gkv1210. Epub 2015 Nov 8.
9
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA.靶向病毒 RNA 主蛋白酶区域的抗 SARS-CoV-2 间隔寡核苷酸。
Antiviral Res. 2024 Oct;230:105992. doi: 10.1016/j.antiviral.2024.105992. Epub 2024 Aug 23.
10
Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice.锁核酸反义寡核苷酸的肝转录谱比较:非靶介导毒性在小鼠中相关途径的证据。
Toxicol Sci. 2014 Mar;138(1):234-48. doi: 10.1093/toxsci/kft278. Epub 2013 Dec 11.

引用本文的文献

1
Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation.内源性核糖核酸酶:通过寡核苷酸触发的RNA失活对转录组进行治疗靶向
Biomolecules. 2025 Jul 4;15(7):965. doi: 10.3390/biom15070965.
2
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals.规避传统抗病毒药物出现耐药性的策略与努力。
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
3
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA.

本文引用的文献

1
RNA therapeutics for neurological diseases.神经疾病的 RNA 疗法。
Br Med Bull. 2023 Sep 12;147(1):50-61. doi: 10.1093/bmb/ldad010.
2
Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.蚊虫传播的黄病毒疫苗研发的最新进展
Viruses. 2023 Mar 23;15(4):813. doi: 10.3390/v15040813.
3
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines.日本脑炎病毒:潜在抗病毒药物和疫苗的最新情况
一种靶向病毒RNA的肽缀合吗啉代寡聚物对小鼠肺部新冠病毒生长的抑制作用。
Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102331. doi: 10.1016/j.omtn.2024.102331. eCollection 2024 Dec 10.
Vaccines (Basel). 2023 Mar 27;11(4):742. doi: 10.3390/vaccines11040742.
4
Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors.SARS-CoV-2 和甲型流感病毒的结构和功能 RNA 基序作为病毒抑制剂的靶标。
Int J Mol Sci. 2023 Jan 8;24(2):1232. doi: 10.3390/ijms24021232.
5
Clinical Pharmacokinetics of Approved RNA Therapeutics.已批准的 RNA 治疗药物的临床药代动力学。
Int J Mol Sci. 2023 Jan 1;24(1):746. doi: 10.3390/ijms24010746.
6
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.反义寡核苷酸临床前安全性评估的考虑因素。
Nucleic Acid Ther. 2023 Jan;33(1):1-16. doi: 10.1089/nat.2022.0061. Epub 2022 Dec 28.
7
Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).靶向开放阅读框1b的反义寡核苷酸可阻断严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的复制。
Front Microbiol. 2022 Oct 26;13:915202. doi: 10.3389/fmicb.2022.915202. eCollection 2022.
8
Antiviral Activity of Oligonucleotides Targeting the SARS-CoV-2 Genomic RNA Stem-Loop Sequences within the 3'-End of the ORF1b.靶向开放阅读框1b(ORF1b)3'端SARS-CoV-2基因组RNA茎环序列的寡核苷酸的抗病毒活性
Pathogens. 2022 Nov 1;11(11):1286. doi: 10.3390/pathogens11111286.
9
Japanese Encephalitis in Australia - A Sentinel Case.澳大利亚的日本脑炎——一个哨点病例。
N Engl J Med. 2022 Aug 18;387(7):661-662. doi: 10.1056/NEJMc2207004.
10
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.针对甲型流感病毒和 SARS-CoV-2 关键保守病毒 RNA 二级结构的可编程抗病毒药物。
Nat Med. 2022 Sep;28(9):1944-1955. doi: 10.1038/s41591-022-01908-x. Epub 2022 Aug 18.